Showing results (1-10 of 173) with videos related to
Sort By:
Pageof 18
Expert Review of Hematology|November 19, 2024
Rivaroxaban plus aspirin after lower-extremity revascularizationGraham R McClure, John EikelboomThe American Journal of Medicine|September 3, 2016
Bleeding with Direct Oral Anticoagulants vs Warfarin: Clinical ExperienceJohn Eikelboom, Geno MerliThe American Journal of Emergency Medicine|October 5, 2016
Bleeding with direct oral anticoagulants vs warfarin: clinical experienceJohn Eikelboom, Geno MerliThrombosis and Haemostasis|October 16, 2015
Incorporating edoxaban into the choice of anticoagulants for atrial fibrillationJeffrey I Weitz, John EikelboomCatheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 29, 2021
Percutaneous closure of a post-surgical ascending aortic pseudoaneurysm with an amplatzer septal occluder device and steerable guiding sheathGraham R McClure, Geemitha Ratnayake, Albert Chan, et al.The Canadian Journal of Cardiology|March 1, 2022
Antithrombotic Therapy in Peripheral Artery Disease: Risk Stratification and Clinical Decision MakingGraham R McClure, Eric Kaplovitch, Noel Chan, et al.Seminars in Thrombosis and Hemostasis|April 12, 2007
Platelet function testing: quality assuranceCatherine P M Hayward, John EikelboomFuture Cardiology|July 8, 2020
Rivaroxaban for the prevention of major adverse cardiovascular events in patients with coronary or peripheral artery diseaseMatt Wheeler, Noel Chan, John EikelboomJournal of the American College of Cardiology|March 20, 2003
The evolving role of direct thrombin inhibitors in acute coronary syndromesJohn Eikelboom, Harvey White, Salim YusufBMJ Open|September 17, 2021
Ross for Valve replacement In AduLts (REVIVAL) pilot trial: rationale and design of a randomised controlled trialRichard Whitlock, Emilie Belley-Cote, Filip Rega, et al.Pageof 18